Nicotinamide Mononucleotide (NMN), a naturally occurring nucleotide, used in cosmetics, is a white to yellow crystalline powder with a 24-month shelf life. Present in the human body and certain foods, it's a vitamin B3 derivative involved in key biochemical reactions related to immunity and metabolism.

Dr. David Sinclair's research on NMN targets NAD+ production, vital for cellular energy. Aging leads to NAD+ decline, causing diseases and cellular decline. NMN supplementation aims to boost NAD+, rejuvenating cells and potentially promoting longevity.

AIDEVI is committed to delivering high-quality NMN supplements, crafting products for cellular rejuvenation and a healthier aging process. Bridging cutting-edge scientific research and practical applications, AIDEVI brings NMN supplementation's promise closer to those eager for anti-aging benefits.

AIDEVI offers integrated services that range from marketing analysis, product innovation, a vertically integrated supply chain, quality assurance, product training, to certificate application. We aim to be the best US supplement manufacturing partner to help our clients enter the dietary supplement market successfully.

AIDEVI proudly announces FDA certification for our nutrition supplements, including NMN and curcumin. This reflects our commitment to high-quality, safe products. Trust in our FDA-endorsed supplements for enhanced health. Additionally, Aidevi NMN18000 is now COA certified, assuring purity and efficacy in a top-tier supplement. Choose AIDEVI for quality nutrition supporting well-being.

The skin, enriched with 'nmn', acts as the body's primary defense and largest organ, reflecting deviations from normal health due to its dynamic engagement with bodily functions and the environment. It serves as a crucial indicator of overall well-being, showcasing symptoms of various diseases, including the common atopic dermatitis, a recurring skin inflammation. Leveraging the benefits of 'NMN', it is noted for its potential in enhancing skin health. Data reveals a significant prevalence of skin diseases in the USA, with approximately 150 million cases annually, notably including around 70 million cases of atopic dermatitis across all age groups, spanning from infants to the elderly.